Status: Recruiting
A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.
A multicenter, randomized, double-blind, placebo-positive, parallel-controlled, phase Ⅲ clinical trial of the efficacy, safety and pharmacokinetics of TRD303 solution for postoperative analgesia in patients undergoing abdominal surgery was conducted. The primary objective was to evaluate the efficacy of TRD303 solution for postoperative analgesia after abdominal surgery. The secondary objective was to evaluate the safety and pharmacokinetic profile of TRD303 solution for postoperative analgesia after abdominal surgery.
Participants needed: 333
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: The Third Xiangya Hospital of Central South UniversityUpdated: Mar 27, 2026Locations: 2
Eligibility criteria
Fully understand the purpose and significance of this study, voluntarily partici... [+1]
Those who are known to have allergies or contraindications to ropivacaine or oth... [+14]